Diabetes Complications Flashcards

1
Q

complications

A

-microvascular
-macrovascular
-dementia
-ED
-psychiatric

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

screening

A

At annual review=
-Digital Retinal Screening
-Foot Risk Assessment
-Urine Albumin:Creatinine Ratio; Creatinine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

microvascular comps

A

Neuropathy
Nephropathy
Retinopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Diabetic Eye Disease (5)

A

-Diabetic Retinopathy
-Diabetic Macular Oedema (Maculopathy)
-Cataract- clouding of the lens (develops earlier in people with diabetes)
-Glaucoma- increase in fluid pressure in the eye leading to optic nerve damage. 2 x more common in diabetes
-Acute hyperglycaemia- visual blurring (reversible)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

terminology (4)

A

Haemorrages: Dot/ Blot/ Flame

Cotton Wool Spots: Ischaemic Areas

Hard Exudates: Lipid break down products

IRMA: Intra-retinal microvascular abnormalities (abnormalities of blood vessels/ precursor to neovascularisation but blood vessels are patent (not leaking))

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Retinopathy- STAGES (5)

A

R0- no disease
R1-Mild non-proliferative (Background)
R2-Moderate non-proliferative
R3-Severe non-proliferative
R4-Proliferative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

R0 (2)

A

no disease
rescreen in 24 motnhs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

R1(4)

A

mild

microanuerysms

flame exudates

over 4 blot haemorrhages in one or both hemifields
and/ or cotton wool spots

rescreen in 12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

R2 (2)

A

over 4 blot haemorrhages in one hemifield

rescreen n 6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

R3 (4)

A

over 4 blot haemorrhages in both hemifields

intra-retinal microvasc comps (IRMA)

venous bleeding

refer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

R4 (5)

A

NVD

NVE

vitreous haemorrhage

retinal detachment

refer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Retinopathy Treatment (6)

A

Laser – pan retinal photocoagulation
-Crude but effective
-Mainstay of treatment
-Reduces oxygen requirement of retina
-Reduces ischaemia that is driving the retinopathy

Vitrectomy – if a vitreal haemorrhage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Diabetic macular oedema (3)

A

-Optical Coherence Tomography is used to
assess oedema
-Intravitreal Anti-VEGF is now mainstay of treatment
(Vascular Endothelial Growth Factor)
-Grid laser to macula may be required

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Nephropathy

A

progressive kidney disease caused by damage to the capillaries in the kidneys’ glomeruli. It is characterized by proteinuria and diffuse scarring of the glomeruli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Consequences of Diabetic Nephropathy (3)

A

-Development of hypertension
-Relentless decline in renal function
reduction in GFR of 1 ml/min/month if untreated
-Accelerated vascular disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

ACR + PCR (2)

A

ACR = Albumin:Creatinine Ratio
PCR = Protein:Creatinine Ratio

17
Q

Urinary Proteinuria (3)

A

ACR <3.5 (female); <2.5 (male)- normal

ACR <30, PCR <50- microalbuminuria

ACR >30 PCR>50- Proteinuria (overt nephropathy)

18
Q

How to interpret urine protein measures

A

Measure protein:creatinine ratio
-Assume daily creatinine excretion is 10mmol, so ratio 100mg/mmol = 1g/day
-SO MULTIPLY BY 10

ACR vs PCR
-Albumin is a component of total protein
-ACR is lower than PCR for a given degree of proteinuria

19
Q

treatment for nephropathy (3)

A

ACE/ARB as first line

Diabetic patients with microalbuminuria should be started on an SGLT2i (irrespective of HBA1c)

Manage other vascular complications e.g. discourage smoking, assess fasting lipid profile, screen for cardiovascular disease and hypertension

20
Q

prevention nephropathy

A

Good glycaemic control (53mmol/mol) in patients with T2DM should be maintained to reduce the risk of developing diabetic neuropathy (depending on age and other risk factors

21
Q

Neuropathy types (4)

A

Peripheral e.g. pain/ loss of feeling in feet, hands

Proximal e.g.pain in the thighs, hips or buttocks leading to weakness in the legs (Amyotrophy)

Autonomic e.g. changes in bowel, bladder function, sexual response, sweating, heart rate, blood pressure

Focal Neuropathy e.g. sudden weakness in one nerve or a group of nerves causing muscle weakness or pain e.g. carpal tunnel, ulnar mono neuropathy, foot drop, bells palsy, cranial nerve palsy

22
Q

Risk factors for Neuropathy (8)

A

Increased length of diabetes
Poor glycaemic control
Type 1 diabetes > Type 2 diabetes
High Cholesterol/ Lipids
Smoking
Alcohol
Inherited Traits (genes)
Mechanical Injury

23
Q

Peripheral Neuropathy symptoms

A

Distal symmetric or sensorimotor neuropathy
“glove & stocking distribution”

24
Q

Peripheral Neuropathy symptoms (5)

A

Numbness/ insensitivity
Tingling/ burning
Sharp pains or cramps
Sensitivity to touch
Loss of balance and coordination

25
Q

Peripheral Neuropathy consequences (3)

A

-charcot foot
-foor ulcer
-painless ulcer

26
Q

Painful Neuropathy treatment (2)

A

amitriptyline (off-label), duloxetine, gabapentin, or pregabalin; combinations not recommended. Titrate up as needed.

If localized neuropathic pain and patient wishes to avoid, or cannot tolerate, oral treatments then topical Capsaicin Cream

27
Q

Proximal Neuropathy

A

Diabetic amyotrophy

Starts with pain in the thighs, hips, buttocks or legs, usually on one side of the body. More common in elderly T2D. Proximal muscle weakness. Often associated with marked weight loss.

28
Q

Autonomic Neuropathy

A

Autonomic neuropathy affects the nerves regulating heart rate and blood pressure as well as control of internal organs such as those involved in gastric motility, respiratory function, urination, sexual function and vision.

29
Q

Autonomic Neuropathy – the gut (4)

A

Digestive System

Gastric slowing/ frequency- Constipation/ Diarrhea (sometimes both).

Gastroparesis (slow stomach emptying) -persistent nausea and vomiting, bloating, and loss of appetite.
Can make blood glucose levels fluctuate widely, due to abnormal food digestion.

Oesophagus nerve damage- may make swallowing difficult, digestive system can lead to weight loss

30
Q

Gastroparesis Treatment (8)

A

Improved glycaemic control

Dietary - smaller, more frequent food portions. Low fat. Low in fiber. If severe may need liquid meals

Promotility drugs such as metoclopramide, domperidone, and erythromycin

anti-nausea medications such as prochlorperazine and serotonin antagonists such as ondansetron.

Abdominal pain in gastroparesis include nonsteroidal anti-inflammatory drugs (NSAIDs), low dose tricyclic antidepressants, gabapentin, tramadol and fentanyl.

Consider a trial of metoclopramide, domperidone, or erythromycin

Botulinum Toxin

Gastric Pacemaker

31
Q

Autonomic Neuropathy Sweat Glands (4)

A

Autonomic neuropathy can affect the nerves that control sweating- prevents the sweat glands from working properly.

The body cannot regulate its temperature as it should. Nerve damage can also cause profuse sweating at night or while eating.
‘Gustatory Sweating’

Extremes of anhidrosis and hyperhidrosis occur in 10% to 75% of people with diabetic autonomic neuropathy.

Treatment: Topical glycopyrrolate, clonidine, botulinum toxin

32
Q

Autonomic Neuropathy - Heart and Blood Vessels (3)

A

Cardiovascular system nerve damage interferes with the body’s ability to adjust blood pressure and heart rate.

Blood pressure may drop sharply after sitting or standing, causing a person to feel light-headed/ faint.

Heart rate may stay high, instead of rising and falling in response to normal body functions and physical activity

33
Q

Mononeuropathy

A

VI cranial nerve palsy

Carpal tunnel syndrome